MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifs

Experimental and Molecular Pathology

Volumn 96, Issue 2, 2014, Pages 242-249

  Fan, Xuesong ^a   Wang, Enshi ^a   Wang, Xianyun ^a   Cong, Xiangfeng ^a   Chen, Xi ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Atherosclerosis; Coronary plaque instability; MiR 21; MMP 9; RECK

Indexed keywords

GELATINASE B; MICRORNA 21; SMALL INTERFERING RNA; CYSTEINE-RICH PROTEIN, MAMMALIAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MICRORNA; MIRN21 MICRORNA, HUMAN; PROTEIN; RECK PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROTEIN EXPRESSION; PROTEIN SECRETION; RECK GENE; AGED; ATHEROSCLEROTIC PLAQUE; BIOSYNTHESIS; BLOOD; CORONARY ARTERY DISEASE; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROTEIN MOTIF;

ADULT; AGED; AMINO ACID MOTIFS; CORONARY ARTERY DISEASE; FEMALE; GPI-LINKED PROTEINS; HUMANS; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 9; MICRORNAS; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PROTEINS; RNA, SMALL INTERFERING;

EID: 84896055980     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.02.009     Document Type: Article

References (36)

1. Alexander C.M., Hansell E.J., Behrendtsen O., Flannery M.L., Kishnani N.S., Hawkes S.P., et al. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 1996, 122(6):1723-1736. (Jun).
2. Ambros V. The functions of animal microRNAs. Nature 2004, 431(7006):350-355. (Sep 16).
3. Ardi V.C., Kupriyanova T.A., Deryugina E.I., Quigley J.P. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(51):20262-20267. (Dec 18).
4. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297. (Jan 23).
5. Caolo V., Schulten H.M., Zhuang Z.W., Murakami M., Wagenaar A., Verbruggen S., et al. Soluble Jagged-1 inhibits neointima formation by attenuating Notch-Herp2 signaling. Arterioscler. Thromb. Vasc. Biol. 2011, 31(5):1059-1065. (May).
6. Cardellini M., Menghini R., Martelli E., Casagrande V., Marino A., Rizza S., et al. TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 2009, 58(10):2396-2401. (Oct).
7. Carrington J.C., Ambros V. Role of microRNAs in plant and animal development. Science 2003, 301(5631):336-338. (Jul 18).
8. Cheng A.M., Byrom M.W., Shelton J., Ford L.P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005, 33(4):1290-1297.
9. Finn A.V., Nakano M., Narula J., Kolodgie F.D., Virmani R. Concept of vulnerable/unstable plaque. Arterioscler. Thromb. Vasc. Biol. 2010, 30(7):1282-1292. (Jul).
10. Gabriely G., Wurdinger T., Kesari S., Esau C.C., Burchard J., Linsley P.S., et al. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol. Cell. Biol. 2008, 28(17):5369-5380. (Sep).
11. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 1994, 94(6):2493-2503. (Dec).
12. Han L., Yue X., Zhou X., Lan F.M., You G., Zhang W., et al. MicroRNA-21 expression is regulated by beta-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK. CNS Neurosci. Ther. 2012, 18(7):573-583. (Jul).
13. Hansson G.K., Hermansson A. The immune system in atherosclerosis. Nat. Immunol. 2011, 12(3):204-212. (Mar).
14. Hashimi S.T., Fulcher J.A., Chang M.H., Gov L., Wang S., Lee B. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 2009, 114(2):404-414. (Jul 9).
15. Hoekstra M., van der Lans C.A., Halvorsen B., Gullestad L., Kuiper J., Aukrust P., et al. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem. Biophys. Res. Commun. 2010, 394(3):792-797. (Apr 9).
16. Hwang H.W., Mendell J.T. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer 2006, 94(6):776-780. (Mar 27).
17. Ji R., Cheng Y., Yue J., Yang J., Liu X., Chen H., et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ. Res. 2007, 100(11):1579-1588. (Jun 8).
18. Kroh E.M., Parkin R.K., Mitchell P.S., Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010, 50(4):298-301. (Apr).
19. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473(7347):317-325. (May 19).
20. Liu C., Yu J., Yu S., Lavker R.M., Cai L., Liu W., et al. MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J. Hepatol. 2010, 53(1):98-107. (Jul).
21. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(30):10513-10518. (Jul 29).
22. Muller J.E., Tawakol A., Kathiresan S., Narula J. New opportunities for identification and reduction of coronary risk: treatment of vulnerable patients, arteries, and plaques. J. Am. Coll. Cardiol. 2006, 47(8 Suppl.):C2-C6. (Apr 18).
23. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 1997, 378(3-4):151-160. (Mar-Apr).
24. Narula J., Nakano M., Virmani R., Kolodgie F.D., Petersen R., Newcomb R., et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J. Am. Coll. Cardiol. 2013, 61(10):1041-1051. (Mar 12).
25. Opdenakker G., Masure S., Proost P., Billiau A., van Damme J. Natural human monocyte gelatinase and its inhibitor. FEBS Lett. 1991, 284(1):73-78. (Jun 17).
26. Raitoharju E., Lyytikainen L.P., Levula M., Oksala N., Mennander A., Tarkka M., et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 2011, 219(1):211-217. (Nov).
27. Raitoharju E., Oksala N., Lehtimaki T. MicroRNAs in the atherosclerotic plaque. Clin. Chem. 2013, 59(12):1708-1721. (Dec).
28. Schmeier S., MacPherson C.R., Essack M., Kaur M., Schaefer U., Suzuki H., et al. Deciphering the transcriptional circuitry of microRNA genes expressed during human monocytic differentiation. BMC Genomics 2009, 10:595.
29. Selaru F.M., Olaru A.V., Kan T., David S., Cheng Y., Mori Y., et al. MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology 2009, 49(5):1595-1601. (May).
30. Surks H.K., Riddick N., Ohtani K. M-RIP targets myosin phosphatase to stress fibers to regulate myosin light chain phosphorylation in vascular smooth muscle cells. J. Biol. Chem. 2005, 280(52):42543-42551. (Dec 30).
31. Tomlinson M.L., Garcia-Morales C., Abu-Elmagd M., Wheeler G.N. Three matrix metalloproteinases are required in vivo for macrophage migration during embryonic development. Mech. Dev. 2008, 125(11-12):1059-1070. (Nov-Dec).
32. Tsai P.C., Liao Y.C., Wang Y.S., Lin H.F., Lin R.T., Juo S.H. Serum microRNA-21 and microRNA-221 as potential biomarkers for cerebrovascular disease. J. Vasc. Res. 2013, 50(4):346-354.
33. van Grevenynghe J., Rion S., Le Ferrec E., Le Vee M., Amiot L., Fauchet R., et al. Polycyclic aromatic hydrocarbons inhibit differentiation of human monocytes into macrophages. J. Immunol. 2003, 170(5):2374-2381. (Mar 1).
34. Weber M., Baker M.B., Moore J.P., Searles C.D. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem. Biophys. Res. Commun. 2010, 393(4):643-648. (Mar 19).
35. Welgus H.G., Campbell E.J., Cury J.D., Eisen A.Z., Senior R.M., Wilhelm S.M., et al. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J. Clin. Invest. 1990, 86(5):1496-1502. (Nov).
36. Young D.A., Lowe L.D., Clark S.C. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity. J. Immunol. 1990, 145(2):607-615. (Jul 15).